TNF and Parkinson disease: Other examples include Angiopep, a peptide used to target nanoparticles loaded with therapeutic molecules to brains in e.g., Parkinson’s disease [13] and the tumor homing NRG-peptide fused together with tumor necrosis factor α (TNFα) to induce anti-tumor and toxic reactions towards tumor cells [36,37].